Welcome to LookChem.com Sign In|Join Free
  • or
(5aR,6S,6aS)-ethyl 3-((2’,6’-dimethyl-4’-(3-(methylsulfonyl)propoxy)-[1,1‘-biphenyl]-3-yl)methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1544739-75-4

Post Buying Request

1544739-75-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1544739-75-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1544739-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,4,4,7,3 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1544739-75:
(9*1)+(8*5)+(7*4)+(6*4)+(5*7)+(4*3)+(3*9)+(2*7)+(1*5)=194
194 % 10 = 4
So 1544739-75-4 is a valid CAS Registry Number.

1544739-75-4Downstream Products

1544739-75-4Relevant academic research and scientific papers

Facile kinetic profiling of chemical reactions using MISER chromatographic analysis

Zawatzky, Kerstin,Grosser, Shane,Welch, Christopher J.

, p. 5048 - 5053 (2017)

Direct MISER (Multiple Injections in a Single Experimental Run) chromatographic analysis can afford easy to interpret kinetic profiles of chemical reactions without the need for peak integration, data input or graphing. Several examples are presented illustrating how this approach can provide researchers with straightforward access to information-rich kinetic reaction profiles.

ANTIDIABETIC TRICYCLIC COMPOUNDS

-

, (2014/02/16)

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

ANTIDIABETIC TRICYCLIC COMPOUNDS

-

, (2014/02/16)

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1544739-75-4